查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498764

治疗诊断市场，按治疗领域、技术、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Theranostics Market, By Therapeutic Area, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 325 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年治疗诊断市场规模为 23.902 亿美元，2024 年至 2032 年复合年增长率为 13.90%。

治疗诊断市场-市场动态

对精准医疗的日益关注推动了治疗诊断市场

精准医学方法在肿瘤学、神经病学、心臟病学和传染病学等各个医学领域获得了广泛关注。资料显示，2022年全球精准医疗治疗总支出约320亿美元。到 2027 年，预计总支出将增至 1,240 亿美元左右。随着基因组学、蛋白质组学和其他组学技术的进步，医疗保健提供者可以更好地了解疾病的分子机制，并识别有助于预测治疗反应的生物标记。例如，治疗诊断学是一种先进的肺癌精准医学模型，它将个别或目标族群疾病的预防、诊断和治疗结合起来，以适应个别患者的特征。除了临床特征外，它还需要收集和整合肺癌患者的基因组、转录组、蛋白质组和代谢组特性。

治疗诊断市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 13.90% 左右的复合年增长率成长

根据治疗领域细分，预计肿瘤学将在 2023 年显示最大的市场份额

根据最终用户细分，医院和诊所是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

治疗诊断学市场細項分析：

全球治疗诊断市场根据治疗领域、技术、最终用户和地区进行细分。

根据最终用户，市场分为三类：医院和诊所、诊断实验室和其他。透过识别与疾病相关的特定分子标靶，治疗诊断学可以促进标靶治疗的实施。这种方法提高了治疗精确度和有效性，并减少了对健康组织的附带损害。许多治疗诊断技术可以无缝整合到现有的医疗保健基础设施中，使患者和临床医生可以轻鬆使用它们，而无需大量额外的资源或基础设施。

根据治疗领域，市场分为五类：神经系统疾病、免疫系统疾病、心血管疾病、肿瘤和其他疾病。肺癌、子宫颈癌、大肠直肠癌、乳癌和其他癌症在肿瘤科下进一步细分。该市场由肿瘤学领域引领，预计在预测期内将继续领先。这是因为治疗诊断学在癌症治疗中的应用越来越广泛，以减少治疗延迟、消除过程中的许多步骤并加强患者护理。

治疗诊断市场-地理洞察

由于完善的医疗保健系统、强大的研究机构和有利的监管框架，北美地区在治疗诊断的进步方面往往处于领先地位。尤其是美国，在治疗诊断的开发和应用方面拥有几个关键参与者。北美拥有许多积极参与治疗诊断研究和开发的领先製药公司。这些公司拥有资源和专业知识来加速治疗诊断产品的商业化并将其推向市场。由于医疗基础设施投资增加、慢性病盛行率上升以及对精准医疗的日益重视，中国、印度和韩国等新兴经济体的治疗诊断正在快速成长。

治疗诊断市场-竞争格局：

专门从事诊断影像技术的公司也在治疗诊断市场上竞争。他们开发用于疾病诊断和监测的成像剂和技术。例子包括 GE Healthcare、Siemens Healthineers 和 Philips Healthcare。放射性製药公司专注于治疗诊断中使用的放射性药物的开发和生产。这些公司在为癌症等各种疾病提供标靶治疗方面发挥着至关重要的作用。製药公司、诊断公司和研究机构等不同利害关係人之间的合作在治疗诊断市场中很常见。这些合作关係透过利用互补的专业知识和资源，促进治疗诊断产品的开发和商业化。例如，生物梅里埃与葛兰素史克签署了一项协议，开发一种预测测试，帮助临床医生为不同部位的乳癌患者选择最合适的治疗方法。

最近的发展：

2023 年 6 月，ICPO 基金会和 FMRI 最近透露了一项参考中心合作，将提高放射分子精准肿瘤学 (RPO) 的全球教育标准，并协助在印度建立新型治疗诊断中心。

目录

第一章：治疗诊断市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按治疗领域分類的治疗诊断市场片段
    • 按技术分類的治疗诊断市场片段
    • 最终使用者的治疗诊断市场片段
    • 按国家/地区分類的治疗诊断市场摘要
    • 按地区分類的治疗诊断市场片段
  • 竞争洞察

第 3 章：治疗诊断主要市场趋势

  • 治疗诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 治疗诊断市场限制
    • 市场限制影响分析
  • 治疗诊断市场机会
  • 治疗诊断市场未来趋势

第 4 章：治疗诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：治疗诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：治疗诊断市场格局

  • 2023 年治疗诊断市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：治疗诊断市场 - 按治疗领域

  • 概述
    • 按治疗领域分類的细分市场占有率分析
    • 肿瘤学
      • 乳癌
      • 肺癌
      • 大肠直肠癌
      • 子宫颈癌
      • 其他的
    • 心血管疾病
    • 免疫系统疾病
    • 神经系统疾病
    • 其他的

第 8 章：治疗诊断市场 - 按技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • 聚合酶炼式反应 (PCR)
    • 免疫组织化学 (IHC)
    • 定序
    • 原位杂交 (ISH)
    • 其他的

第 9 章：治疗诊断市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 诊断实验室
    • 其他的

第 10 章：治疗诊断市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美治疗诊断主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模与预测（按治疗领域）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲治疗诊断主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按治疗领域）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区治疗诊断主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按治疗领域）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲治疗诊断主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按治疗领域）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲治疗诊断主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按治疗领域）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 治疗诊断产业

  • 竞争仪表板
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • AmeriPath, Inc.
    • Beckman Coulter, Inc.
    • Foundation Medicine, Inc.
    • Hoffmann-La Roche Ltd
    • Myriad Genetics, Inc.
    • Focus Diagnostics
    • Abbott Laboratories
    • Illumina, Inc.
    • QIAGEN
    • Agilent Technologies, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2935

REPORT HIGHLIGHT

Theranostics Market size was valued at USD 2,390.20 million in 2023, expanding at a CAGR of 13.90% from 2024 to 2032.

The theranostics market involves the combination of diagnostics with therapeutics to create personalized treatment plans for patients. This approach allows for tailored therapy based on an individual's specific genetic makeup, disease state, and other relevant factors. The key drivers of the theranostics market are the growing focus on personalized medicine and precision healthcare. By using diagnostic tests to identify biomarkers or specific molecular targets, healthcare providers can better match patients with the most effective treatments, potentially improving outcomes and reducing adverse effects. Furthermore, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, has fueled the demand for innovative therapeutic approaches.

Theranostics Market- Market Dynamics

Increasing focus on precision medicines propelling the theranostics market

Precision medicine approaches have gained traction across various medical fields, including oncology, neurology, cardiology, and infectious diseases. As per data, in 2022, total spending on treatments with precision medicine stood at some 32 billion U.S. dollars globally. By 2027, it is projected that total spending will increase to around 124 billion dollars. With advancements in genomics, proteomics, and other omics technologies, healthcare providers can better understand the molecular mechanisms underlying diseases and identify biomarkers that help predict treatment response. Forr instance, Theranostics, an advanced model of precision medicine for lung cancer, combines prevention, diagnosis, and treatment for individual or targeted population disorders to accommodate individual patient characteristics. In addition to clinical traits, it entails gathering and integrating lung cancer patient's genome, transcriptome, proteome, and metabolome properties.

Theranostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.90% over the forecast period (2024-2032)

Based on Therapeutic Area segmentation, oncology was predicted to show maximum market share in the year 2023

Based on end-user segmentation, Hospitals, and Clinics was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Theranostics Market- Segmentation Analysis:

The Global Theranostics Market is segmented on the basis of Therupatic Area, Technology, End User, and Region.

The market is divided into three categories based on end-users: Hospitals and Clinics, Diagnostic Laboratories, and Others. By identifying specific molecular targets associated with diseases, theranostics facilitates targeted therapy delivery. This approach enhances treatment precision, and effectiveness, and reduces collateral damage to healthy tissues. Many theranostic techniques can be seamlessly integrated into existing healthcare infrastructure, making them readily accessible to patients and clinicians without requiring significant additional resources or infrastructure.

The market is divided into five categories based on therapeutic area: Neurological conditions, immunological disorders, cardiovascular illnesses, oncology, and other conditions. Lung cancer, cervical cancer, colorectal cancer, breast cancer, and other cancers are further subdivided under the oncology section. The market was led by the oncology segment, which is anticipated to continue leading during the projection period. This is because theranostics is becoming more widely used in cancer therapy to reduce treatment delays, eliminate many steps in the process, and enhance patient care.

Theranostics Market- Geographical Insights

North America region often leads in theranostics advancements due to well-established healthcare systems, strong research institutions, and favorable regulatory frameworks. The United States, in particular, hosts several key players in theranostics development and adoption. North America is home to many leading pharmaceutical companies that are actively involved in theranostics research and development. These companies have the resources and expertise to accelerate the commercialization of theranostic products and bring them to market. Emerging economies like China, India, and South Korea are witnessing rapid growth in theranostics due to increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, and a growing emphasis on precision medicine.

Theranostics Market- Competitive Landscape:

Companies specializing in diagnostic imaging technologies also compete in the theranostics market. They develop imaging agents and technologies used for the diagnosis and monitoring of diseases. Examples include GE Healthcare, Siemens Healthineers, and Philips Healthcare. Radiopharmaceutical companies focus on the development and production of radiopharmaceuticals used in theranostics. These companies play a crucial role in providing targeted therapies for various diseases such as cancer. Collaboration between different stakeholders such as pharmaceutical companies, diagnostic companies, and research institutions is common in the theranostics market. These partnerships facilitate the development and commercialization of theranostic products by leveraging complementary expertise and resources. For instance, bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients.

Recent Developments:

In June 2023, The ICPO Foundation and FMRI recently revealed a reference center cooperation that will foster global standards of education in Radiomolecular Precision Oncology (RPO) and assist in setting up novel Theranostics Centres in India.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERANOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific Inc.

AmeriPath, Inc.

Beckman Coulter, Inc.

Foundation Medicine, Inc.

Hoffmann-La Roche Ltd

Myriad Genetics, Inc.

Focus Diagnostics

Abbott Laboratories

Illumina, Inc.

QIAGEN

Agilent Technologies, Inc.

Others

GLOBAL THERANOSTICS MARKET, BY THERUPATIC AREA - MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Others
  • Cardiovascular Diseases
  • Immunological Disorders
  • Neurological Disorders
  • Others

GLOBAL THERANOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • Sequencing
  • In Situ Hybridization (ISH)
  • Others

GLOBAL THERANOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

GLOBAL THERANOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Theranostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Theranostics Market Snippet by Therupatic Area
    • 2.1.2. Theranostics Market Snippet by Technology
    • 2.1.3. Theranostics Market Snippet by End User
    • 2.1.4. Theranostics Market Snippet by Country
    • 2.1.5. Theranostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Theranostics Key Market Trends

  • 3.1. Theranostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Theranostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Theranostics Market Opportunities
  • 3.4. Theranostics Market Future Trends

4. Theranostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Theranostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Theranostics Market Landscape

  • 6.1. Theranostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Theranostics Market - By Therupatic Area

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therupatic Area, 2023 & 2032 (%)
    • 7.1.2. Oncology
      • 7.1.2.1. Breast Cancer
      • 7.1.2.2. Lung Cancer
      • 7.1.2.3. Colorectal Cancer
      • 7.1.2.4. Cervical Cancer
      • 7.1.2.5. Others
    • 7.1.3. Cardiovascular Diseases
    • 7.1.4. Immunological Disorders
    • 7.1.5. Neurological Disorders
    • 7.1.6. Others

8. Theranostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. Polymerase Chain Reaction (PCR)
    • 8.1.3. Immunohistochemistry (IHC)
    • 8.1.4. Sequencing
    • 8.1.5. In Situ Hybridization (ISH)
    • 8.1.6. Others

9. Theranostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Others

10. Theranostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Theranostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Theranostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Theranostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Theranostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Theranostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Theranostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. AmeriPath, Inc.
    • 11.2.3. Beckman Coulter, Inc.
    • 11.2.4. Foundation Medicine, Inc.
    • 11.2.5. Hoffmann-La Roche Ltd
    • 11.2.6. Myriad Genetics, Inc.
    • 11.2.7. Focus Diagnostics
    • 11.2.8. Abbott Laboratories
    • 11.2.9. Illumina, Inc.
    • 11.2.10. QIAGEN
    • 11.2.11. Agilent Technologies, Inc.
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Theranostics Market: Therupatic Area Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therupatic Area
  • TABLE Global Theranostics Market, by Therupatic Area 2019-2032 (USD Million)
  • TABLE Theranostics Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Theranostics Market, by Technology 2019-2032 (USD Million)
  • TABLE Theranostics Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Theranostics Market, by End User 2019-2032 (USD Million)
  • TABLE Theranostics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Theranostics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by End User, 2019-2032 (USD Million)